SCHEMBL33378032

SCHEMBL33378032

COc1ccc(Nc2cc(Cl)nc3c(C(C)C)cnn23)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 10/20 0.41
▸ GSK3B P49841 4/20 0.41
▸ CDK7 P50613 6/20 0.37
▸ CSNK2A1 P68400 1/20 0.36
▸ BTK Q06187 6/20 0.36
▸ SRC P12931 5/20 0.36
▸ LYN P07948 3/20 0.36
▸ CCNH P51946 3/20 0.35
▸ MNAT1 P51948 2/20 0.35
▸ CCNT1 O60563 2/20 0.35
▸ CDK1 P06493 2/20 0.35
▸ CDK4 P11802 2/20 0.35
▸ CCNB1 P14635 2/20 0.35
▸ CCND1 P24385 2/20 0.35
▸ CCNE1 P24864 2/20 0.35
▸ CDK8 P49336 2/20 0.35
▸ CDK9 P50750 2/20 0.35
▸ CDK6 Q00534 2/20 0.35
▸ CDK5 Q00535 2/20 0.35
▸ CDK5R1 Q15078 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377822 0.85 CDK7 (0.52) CDK2GSK3BCDK7CCNHMNAT1
SCHEMBL33378029 0.83 CDK2 (0.41) CDK2GSK3BCDK7BTKSRC
SCHEMBL33378019 0.82 CDK2 (0.42) CDK2GSK3BCDK7CSNK2A1BTK
SCHEMBL33377988 0.81 CDK2 (0.42) CDK2GSK3BCDK7CCNHMNAT1
SCHEMBL33377919 0.80 CDK2 (0.41) CDK2GSK3BCDK7CCNHMNAT1
SCHEMBL33377933 0.80 GRM5 (0.43) CDK2GSK3BCDK7CCNHMNAT1
SCHEMBL33377934 0.80 CDK2 (0.43) CDK2GSK3BCDK7CCNHMNAT1
SCHEMBL33378009 0.78 CDK7 (0.52) CDK2CDK7CCNHMNAT1CCNT1
SCHEMBL33378000 0.78 CDK2 (0.49) CDK2GSK3BCDK9
SCHEMBL33377883 0.77 CDK2 (0.43) CDK2GSK3BCDK7CCNHMNAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback